Clinical Trial Update: COVID-19 Convalescent Plasma [EARLY_Phase 1]

View source ↗

Summary

EARLY_PHASE1 trial of COVID-19 convalescent plasma completed; results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus

Drugs mentioned

• COVID-19 convalescent plasma

Snippet

Sponsor: University of Chicago | Conditions: Coronavirus | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-02-28